Literature DB >> 11982953

Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease.

Carsten Otto1, H Christian Geiss, Ester Laubach, Peter Schwandt.   

Abstract

Direct adsorption of lipoproteins (DALI) apheresis has been shown to reduce effectively low-density lipoprotein (LDL) cholesterol and lipoprotein (a) concentrations. However, the effects on nontraditional risk indicators such as hemorheology and LDL subtypes have not been investigated so far. Five patients (2 women, 3 men, age 53 +/- 8 years) with coronary artery disease and severe LDL hypercholesterolemia regularly treated with other LDL apheresis devices entered the study and were then treated with DALI for the first time. Hemorheological and lipoprotein parameters were measured before and immediately after the initial DALI apheresis as well as before the fourth DALI apheresis. Compared to baseline (before the first DALI apheresis), the following parameters were significantly improved (p < 0.05) after the first DALI apheresis: LDL cholesterol (69 +/- 28 versus 208 +/- 82 mg/dl) and cholesterol in each LDL subfraction as well as plasma viscosity (1.23 +/- 0.04 versus 1.37 +/- 0.06 mPa), C-reactive protein, native blood viscosity, red cell aggregation, and red cell deformability. When parameters before the fourth DALI apheresis were compared to baseline, LDL cholesterol was still lower, and red cell deformability was still improved while cholesterol in each subfraction showed a statistical trend to lower concentrations (0.08 < p < 0.14). In conclusion, DALI apheresis not only reduces LDL cholesterol but also induced a significant reduction of cholesterol in all LDL subfractions and improved various hemorheological parameters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982953     DOI: 10.1046/j.1526-0968.2002.00366.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  3 in total

1.  Efficacy of low-density lipoprotein apheresis combined with corticosteroids for cholesterol crystal embolism.

Authors:  Katsuya Ishiyama; Toshinobu Sato; Takuhiro Yamaguchi; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2016-04-21       Impact factor: 2.801

2.  HEMOGLOBIN A1c LEVEL HIGHER THAN 9.05% CAUSES A SIGNIFICANT IMPAIRMENT OF ERYTHROCYTE DEFORMABILITY IN DIABETES MELLITUS.

Authors:  Q Li; L Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

Review 3.  The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina.

Authors:  Tina Z Khan; Alison Pottle; Dudley J Pennell; Mahmoud S Barbir
Journal:  Glob Cardiol Sci Pract       Date:  2014-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.